Waverly Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1568787 BIRMINGHAM, AL

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,890,387

-$823,385 QoQ

Shares Held

30,793

-9.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#642

of 2,266 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 3% Shared 0% None 97%

Healthcare · as of Jun 30, 2026

Waverly Advisors, LLC holds $406,112,967 across 14 Drug Manufacturers - General names. GILD ranks #10 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	97,676	$117,155,534
2	ABBV	AbbVie Inc.	322,558	$81,168,495
3	JNJ	Johnson & Johnson	314,877	$79,969,311
4	MRK	Merck & Co., Inc.	260,499	$33,474,121
5	AZN	Astrazeneca PLC	119,233	$22,608,961
6	BMY	Bristol Myers Squibb Co	349,560	$20,141,647
7	GSK	GSK plc	290,593	$15,232,885
8	AMGN	Amgen Inc	41,925	$15,181,881

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,890,387	30,793	-9.0%	Shares	Sole	2026-08-14
2026-03-31	$4,713,772	33,822	+27.8%	Shares	Sole	2026-05-15
2025-12-31	$3,248,682	26,468	+15.6%	Shares	Sole	2026-02-17
2025-09-30	$2,542,011	22,901	-37.1%	Shares	Sole	2025-11-14
2025-06-30	$4,033,894	36,384	+11.3%	Shares	Sole	2025-08-14
2025-03-31	$3,661,457	32,677	+12.0%	Shares	Sole	2025-05-15
2024-12-31	$2,695,448	29,181	+8.6%	Shares	Sole	2025-02-14
2024-09-30	$2,252,026	26,861	-1.4%	Shares	Sole	2024-11-14
2024-06-30	$1,870,034	27,256	+3.0%	Shares	Sole	2024-08-14
2024-03-31	$1,937,828	26,455	+7.8%	Shares	Other	2024-05-15
2023-12-31	$1,988,390	24,545	-49.2%	Shares	Other	2024-02-14
2023-09-30	$3,624,322	48,363	-0.4%	Shares	Other	2023-11-14
2023-06-30	$3,743,212	48,569	-1.7%	Shares	Other	2023-08-15
2023-03-31	$4,098,302	49,395	—	Shares	Other	2023-05-16
No filing history on record for this holder in this stock.